IBOCTADEKIN
UNII X08H9UZ7TO

Substance Identification & Data

This profile provides standardized clinical and technical data for Iboctadekin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) X08H9UZ7TO.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 479198-61-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
X08H9UZ7TO
CAS Registry Number
479198-61-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
IBOCTADEKIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
8576
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
QQ-23
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Iboctadekin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

IBOCTADEKIN

Common Names & Synonyms

HUMAN INTERLEUKIN-18 (RECOMBINANT, EXPRESSED IN ESCHERICHIA COLI)
IBOCTADEKIN [INN]
IBOCTADEKIN [USAN]
IBOCTADEKIN [WHO-DD]
IFN-GAMMA-INDUCING FACTOR
IL-1 GAMMA
IL18
IL-18
INTERFERON GAMMA-INDUCING FACTOR
INTERLEUKIN-1 GAMMA
INTERLEUKIN-18

Technical Codes

SB-485232